Not Yet RecruitingNot Applicable

Effect of Soleus Muscle Kinetic Control Training on Gait and Electromyographic Activity in Patients With Stroke

40 participantsStarted 2025-12-15

Plain-language summary

this study was designed to investigate the effect of soleus muscle kinetic control training on Gait and electromyographic activity of the calf muscle in patients with stroke

Who can participate

Age range

45 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ischemic or hemorrhagic stroke, as confirmed by CT and or MRI scan. * Age of the patients between 45 to 60 years old. * Ability to walk a minimum of 10 m with or without some physical assistance from a therapist (functional ambulation category more than 2). * Demonstrate weakness of the foot muscles, measured by muscle function tests according Medical Research council scale more than 3. * Muscle tone of the affected lower limb ranges from 1 to +1 according to modified Ashworth scale. Exclusion Criteria: * Unilateral neglect, hemianopia, or apraxia * Having any other neurological disorder affecting their lower extremities e.g. MS, Parkinsonism, peripheral neuropathy. * Patients with previous fractures in lower limb (Ankle or foot). * Patients with musculoskeletal disorder such as severe arthritis, ankle surgery, leg length discrepancy or contractures of fixed deformity of ankle joint. * Patients with visual, auditory impairment affecting their ability to complete tasks. * Patients with cognitive impairments

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

muscle amplitude

Timeframe: up to eight weeks

giat function

Timeframe: up to eight weeks

Gait Cycle time

Timeframe: up to eight weeks

step time

Timeframe: up to eight weeks

cadence

Timeframe: up to eight weeks

stance phase percentage

Timeframe: up to eight weeks

swing phase percentage

Timeframe: up to eight weeks

single and double support percentage

Timeframe: up to eight weeks

Trial details

NCT IDNCT07309081

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-15

Contact for this trial

habiba mohamed, master

0 10 90708377 dochabiba4@gmail.com

View on ClinicalTrials.gov More Stroke trials

Who can participate

Age range

45 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

muscle amplitude

Timeframe: up to eight weeks

giat function

Timeframe: up to eight weeks

Gait Cycle time

Timeframe: up to eight weeks

step time

Timeframe: up to eight weeks

cadence

Timeframe: up to eight weeks

stance phase percentage

Timeframe: up to eight weeks

swing phase percentage

Timeframe: up to eight weeks

single and double support percentage

Timeframe: up to eight weeks